Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age–specific mouse model
Open Access
- 10 August 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (15), 3728-3740
- https://doi.org/10.1182/bloodadvances.2020002326
Abstract
It is not clear whether disrupted age-specific hematopoiesis contributes to the complex manifestations in leukemia patients who carry identical mutations, particularly in pediatric and adult patients with similar clinical characteristics. By studying a dual-age–specific mouse model, we demonstrate that (1) loss of Pten during the fetal-to-adult hematopoiesis switch (hematopoiesis switch) causes sustained fetal hematopoiesis, resulting in death in juvenile leukemia; (2) myeloid-biased hematopoiesis in juvenile mice is associated with the sustained fetal properties of hematopoietic stem cells (HSCs); (3) the age specificity of juvenile myelomonocytic leukemia depends on the copy number of Pten and Nf1; (4) single-allelic Pten deletion during the hematopoiesis switch causes constitutive activation of MAPK in juvenile mice with Nf1 loss of heterozygosity (LOH); and (5) Nf1 LOH causes monocytosis in juvenile mice with Pten haploinsufficiency but does not cause lethality until adulthood. Our data suggest that 1 copy of Pten is sufficient to maintain an intact negative-feedback loop of the Akt pathway and HSC function in reconstitution, despite MAPK being constitutively activated in juvenile Pten+/ΔNf1LOH mice. However, 2 copies of Pten are required to maintain the integrity of the MAPK pathway in juvenile mice with Nf1 haploinsufficiency. Our data indicate that previous investigations of Pten function in wild-type mice may not reflect the impact of Pten loss in mice with Nf1 mutations or other genetic defects. We provide a proof of concept that disassociated age-specific hematopoiesis contributes to leukemogenesis and pediatric demise.Keywords
This publication has 43 references indexed in Scilit:
- Developmental changes in hematopoietic stem cell propertiesExperimental & Molecular Medicine, 2013
- Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant miceJCI Insight, 2012
- Temporal Changes in PTEN and mTORC2 Regulation of Hematopoietic Stem Cell Self-Renewal and Leukemia SuppressionCell Stem Cell, 2012
- Distinct B-cell lineage commitment distinguishes adult bone marrow hematopoietic stem cellsProceedings of the National Academy of Sciences of the United States of America, 2012
- Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-1 and marginal zone progenitor lacking B-2 potentialProceedings of the National Academy of Sciences of the United States of America, 2011
- High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patientsBlood, 2009
- Repertoire-based selection into the marginal zone compartment during B cell developmentThe Journal of Experimental Medicine, 2008
- Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell propertiesProceedings of the National Academy of Sciences of the United States of America, 2007
- Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birthProceedings of the National Academy of Sciences of the United States of America, 2006
- Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorderBlood, 2004